Skip to main content
. 2021 Oct 15;2021:9388562. doi: 10.1155/2021/9388562

Table 5.

Comparison of cardiovascular outcomes between the two groups of patients (n, %).

Index Control group (n = 35) Observation group (n = 35) χ 2 value P value
Cardiac death 2 (5.71) 0 (0.00) 2.059 0.151
Recurrent myocardial infarction 3 (8.57) 1 (2.86) 1.061 0.303
Severe arrhythmia 8 (22.56) 2 (5.71) 4.200 0.040
Heart failure 6 (17.14) 1 (2.86) 3.968 0.046
Other cardiovascular adverse events 4 (11.43) 3 (8.57) 0.159 0.690